Meet the VaaS leadership team
Julia Paget, Head of Development, VaaS
Julia joined the VaaS team in 2021 as Head of Development. In this role, Julia leads the development of the VaaS methodology, drawing on her 30 years of public and private sector experience working in the IVF clinic and laboratory, and collaborating with experts across Virtus’ global network. Julia is also responsible for building VaaS partnerships and growing the VaaS client base globally.
Training as an embryologist in the early 90s, Julia has worked in some of the best IVF clinics in the world, including Reproductive Medicine Associates (RMA) and ART Institute of Washington in the United States, Fertility Associates in New Zealand and Lister Fertility Clinic in England. By 2008, Julia had worked in approximately 20 different IVF facilities around the world.
In 2010, Julia co-founded Complete Fertility Centre in the UK, a business that joined the Virtus network in 2018. As Clinic Director, a post she held for more than a decade, Julia was responsible for the running of the fertility clinic and its employees, in addition to the strategic growth of the organisation. From best-practice protocols and quality management systems to operational and administrative needs, Julia has extensive experience across every facet of building, operating and growing a successful fertility business and she brings this deep knowledge and expertise to the VaaS team.
Dr Andrew Kan, Chief Medical Officer, VaaS
Andrew is an experienced fertility specialist with a growing reputation throughout Australasia, due to his understanding and care for patients of different nationalities. He even consults in Singapore monthly and goes often to Bangkok and Shanghai to see patients.
Andrew founded IVF Australia together with 6 other doctors in NSW in 2002. He is highly regarded, providing regular advice to colleagues who are establishing IVF units in Asia.
Andrew’s research interests reflect his personal approach to tailoring treatment to each patient’s clinical and personal needs. For example, he has been examining the effect of different ethnicity on fertility for many years in comparison to Caucasian women and is seeing trends in social and clinical aspects emerge.
Andrew also understands and respects many patients desire to begin treatment with the least invasive methods and is researching optimal treatment progression (including the controversial low dose, lite or mild stimulation IVF) and age related response to IVF for example IVF in women in their twenties and forties – considered age extremes for IVF.
Andrew graduated from the University of Sydney with honours in 1988, before completing his training in obstetrics and gynaecology. He then worked in London for three years in Guys, St Thomas’ and Lister Hospitals, to further his expertise in infertility.
Andrew returned to Sydney to complete his Master of Medicine (Reproductive Health and Genetics) and his sub-specialty certification in Reproductive Endocrinology and Infertility (CREI), and now maintains an appointment as a Conjoint Senior Lecturer at The University of New South Wales.
His special areas of interest include polycystic ovarian syndrome, male infertility, alternative and Chinese medicine and treatment of patients needing donor sperm, oocytes and surrogacy.
Andrew also speaks fluent Mandarin and Cantonese; and has conversational Japanese, Malay and Indonesian.
Kate Munnings, Group Chief Executive Officer
Kate commenced as Group CEO at Virtus Health Limited on 23 March 2020. A qualified lawyer and registered nurse, Kate’s diverse breadth of professional experience equips her to lead the Virtus Health team in continuing to provide their exceptional work that helps people become parents.
Prior to joining Virtus Health, Kate led significant operations including as Chief Operating Officer of Ramsay Health Care Limited’s 72 Australian hospitals; and as Chief Executive, Operations leading a portfolio of largely government contracts across Australia, New Zealand and Melanesia at Transfield Services Limited (now Broadspectrum Limited).
Kate has also been a partner at law firms Corrs Chambers Westgarth and Baker McKenzie; specialising in contract law and also spent eight years as Chief Risk & Legal Officer/Company Secretary at Transfield Services focused on commercial law, risk management and corporate governance.
As a registered nurse, Kate was one of the early specialist in HIV/AIDS nursing at Sydney’s St Vincent’s Hospital.
Kate is currently a Board member of the Digital Health Cooperative Research Centre and previously spent four years on the Board of South Eastern Sydney Local Health District.
Matt Prior, Group Chief Financial Officer
Matt joined Virtus Health in June 2021, and brings a deep understanding of the value drivers in healthcare as well as strong industry experience.
Having been an executive at Cochlear Limited (ASX:COH) since 2015, initially as Head of Strategy and then as Vice President Finance & Commercial Operations - Asia Pacific, Matt had responsibility for driving value across their operations in China, India, Japan, Korea, ASEAN, Australia & New Zealand.
Matt also covered healthcare stocks for close to a decade as an equities analyst at Deutsche Bank, as Head of Healthcare Equities Research Asia Pacific at Bank of America Merrill Lynch, and Head of Equities Research Australia at Evans & Partners. This experience provided Matt with a rich insight into the structure of the industry as well as the impact of regulation and consumer trends. Prior to that, Matt spent a number of years in the corporate finance and valuations team at Deloitte.
Matt gained significant M&A and transactional experience both in Australia and Asia through his time at Deloitte, Bank of America Merrill Lynch and Cochlear.
Teena Pisarev, Chief Operating Officer and Managing Director, NSW/ACT, Singapore and Diagnostics
With more than 20 years working in the private healthcare sector within hospital, diagnostics, pathology and outpatient services, Teena has a broad and extensive understanding of the emerging trends and challenges facing the health industry locally and within Southeast Asia. Over her career Teena, who is a graduate of Griffith University (GC), has worked closely with doctors establishing practices and amalgamating opportunities, led major brownfield healthcare redevelopments, and implemented new services to significantly increase services accessibility and hospital performance. She has a strong ability to engage teams, increase performance and deliver outstanding growth.
During her role as CEO of Icon Cancer Care, she oversaw the divisional expansion via collaboration with VMOs, staff and partner organisations. Through the simplification of processes, strengthening of clinical governance and empowerment of local leaders, Teena delivered strong growth and maintained an engaged and enthusiastic team. This was followed by a period living and working in Singapore and leading the MA expansion into South East Asia, as Regional CEO, where she successfully led the expansion of Icon in South East Asia.
Upon returning to Australia Teena joined Virtus Health in 2019, where she heads operations in multiple business units across Australia and South East Asia. Skilled in strategy planning, business development, change management and healthcare operations her leadership style is simple; supported, engaged clinicians and empowered and well-resourced teams result in exceptional patient care.